Trials / Available
AvailableNCT05522556
Pre-approval Single-patient Expanded Access for Ritlecitinib (PF-06651600)
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- —
Summary
Provide pre-approval single patient Expanded Access (compassionate use) of Ritlecitinib for patients.
Detailed description
In Expanded Access, treating physicians are the Sponsors. Expanded Access requests from treating physicians may be submitted to www.pfizercares.com. Availability will depend on location and country.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ritlecitinib | capsules |
Timeline
- First posted
- 2022-08-31
- Last updated
- 2025-11-18
Source: ClinicalTrials.gov record NCT05522556. Inclusion in this directory is not an endorsement.